ConvaTec Regulatory News (CTEC)

Convatec Director Declaration

Reading, United Kingdom (7 July 2022)

Convatec Group Plc ("Convatec" or "the Company") announces that Sharon O'Keefe, a non-executive director of the Company, has been appointed as a non-executive director of Apollo Endosurgery Inc. (Nasdaq: APEN), with effect from 6 July 2022.

This announcement is made in accordance with Listing Rule 9.6.14R. 

Enquiries 

Analysts and Investors 

Kate Postans, VP Investor Relations, Convatec +44 (0)782 644 7807 

ir@convatec.com 

Media 

Buchanan: Charles Ryland / Chris Lane   +44 (0)207 466 5000  

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92 

About Convatec 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com